FHTX · TickerCove

FHTXFoghorn Therapeutics Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $4.17 · now $4.17 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, FHTX has typically landed between $2.80 and $6.12 — a range of −32.8% to +46.7% from the issuance price $4.17.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,459 overlapping 1 month windows · 2020-10-23 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($4.17) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$4.17 · 18% of range

$3.53 low$7.07 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−0.5%

typical move · IQR 35.2%

−32.8%worst (p90)+46.7%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where FHTX has typically landed a month from the 2026-09-16 close of $4.17 — the range is history, not a prediction.

now $4.17 (+0.0%)
typical $4.15 (-0.5%)
middle 50% $3.41–$4.88
90% range $2.8–$6.12

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,459 windows spanning 2020-10-23 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2023-12-26	−54.1%	−54.1%	+1.8%
2023-12-22	−53.3%	−54.5%	+0.6%
2024-01-02	−53.0%	−53.0%	+0.0%
3 best
2024-01-31	+149.7%	−11.3%	+149.7%
2024-02-05	+140.8%	+0.0%	+181.6%
2024-01-25	+140.1%	−10.2%	+140.1%

1,459 overlapping windows · 2020-10-23 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

33%

−12.1%

n=6

Feb

33%

+14.5%

n=6

Mar

33%

−1.2%

n=6

Apr

33%

−6.6%

n=6

May

33%

−0.6%

n=6

Jun

83%

+7.9%

n=6

Jul

67%

+8.2%

n=6

Aug

50%

+5.8%

n=6

Sep

33%

−9.8%

n=6

Oct

20%

−13.6%

n=5

Nov

67%

+5.7%

n=6

Dec

67%

+19.5%

n=6

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

61 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-06-24	PARSHALL B LYNNE	director	Award / grant	28,000	28,000	Form 4
2026-06-24	GILL SIMBA	director	Award / grant	28,000	28,000	Form 4
2026-06-24	SMITH IAN F	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Lynch Thomas J. Jr.	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Mendelsohn Michael	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Gallagher Neil	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Biller Scott	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Cole Douglas G.	director	Award / grant	28,000	28,000	Form 4
2026-06-24	Duty Stuart	director	Award / grant	28,000	28,000	Form 4
2026-04-10	GOTTSCHALK ADRIAN	director	Gift	59,208	240,792	Form 4
2026-04-10	GOTTSCHALK ADRIAN	director	Gift	59,208	270,912	Form 4
2026-04-09	GOTTSCHALK ADRIAN	director	Gift	47,497	211,704	Form 4
2026-04-09	GOTTSCHALK ADRIAN	director	Gift	47,497	0	Form 4
2026-02-23	Maynard Ryan D	director	Award / grant	400,000	400,000	Form 4
2026-02-05	GOTTSCHALK ADRIAN	director	Award / grant	1,075,000	1,075,000	Form 4
2026-01-30	Bellon Steven F.	officer	Award / grant	300,000	300,000	Form 4
2026-01-30	Cardama Alfonso Quintas	officer	Award / grant	300,000	300,000	Form 4
2026-01-30	LaCascia Michael	officer	Award / grant	295,000	295,000	Form 4
2026-01-30	Costa Carlos	officer	Award / grant	230,000	230,000	Form 4
2026-01-30	Rivkin Anna	officer	Award / grant	165,000	165,000	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	2,235,468	2,235,468	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4
2026-01-13	Flagship Pioneering, LLC	director	Award / grant	1,117,734	1,117,734	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i